Transmission Dynamics of Carbapenemase-Encoding Genes in Carbapenem-Resistant Enterobacter cloacae: A Multi-Hospital Study in China

Study Background and Research Question

Carbapenem-resistant Enterobacter cloacae (CREC) has emerged as a significant clinical threat, ranking third among carbapenem-resistant Enterobacteriaceae in China, following Klebsiella pneumoniae and Escherichia coli (internal_article). The COVID-19 pandemic has further complicated antimicrobial resistance (AMR) patterns, with increased antibiotic use and healthcare disruptions contributing to the rise of multidrug-resistant organisms. A critical mechanism underlying CREC resistance is the acquisition of carbapenemase-encoding genes (CEGs), such as blaNDM−1, blaIMP, and blaKPC−2, yet detailed investigations into their prevalence, genetic context, and transmission, especially during the pandemic, have been scarce (reference_paper). The present study addresses this gap by characterizing CEGs in CREC isolates from eight teaching hospitals in Guangdong Province, China, collected between December 2022 and June 2024, with an emphasis on plasmid localization, transfer mechanisms, and epidemiological patterns (reference_paper).

Key Innovation from the Reference Study

The central innovation of Chen et al.'s study lies in its comprehensive mapping of CEG prevalence, mobility, and clinical distribution in a high-burden setting during the COVID-19 pandemic. Specifically, the study:

• Distinguishes between chromosomal and plasmid localization of key CEGs (notably blaNDM−1), providing direct evidence for the predominance of plasmid-borne resistance determinants.
• Quantifies the efficiency of horizontal gene transfer via conjugation, highlighting the remarkable transferability of certain CEGs among clinical isolates.
• Integrates molecular typing and epidemiological data to correlate resistance gene dissemination with patient demographics, clinical departments, and specimen sources (reference_paper).

This multi-layered approach enables a nuanced understanding of how resistance genes proliferate within and between healthcare facilities, providing actionable insights for infection control and molecular surveillance.

Methods and Experimental Design Insights

The study combined multiple molecular and microbiological techniques to elucidate the genetic and phenotypic profiles of CREC isolates:

• Isolate Collection: 54 non-duplicate CREC strains were sampled from eight tertiary teaching hospitals in Guangdong Province over an 18-month period.
• CEG Screening: Polymerase Chain Reaction (PCR) was used to detect blaNDM−1, blaIMP, and blaKPC−2 genes. Variable temperature Sodium Dodecyl Sulfate (SDS) plasmid elimination assays distinguished between chromosomal and plasmid localization (reference_paper).
• Resistance Phenotyping: Broth microdilution determined resistance to imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin.
• Plasmid Conjugation Experiments: Assessed horizontal transfer potential of CEGs.
• ERIC-PCR Genotyping: Used to categorize isolates into 17 genotypes and map their prevalence across hospitals and departments.
• Mobile Genetic Elements (MGEs) Typing: PCR-based detection of six MGE types, with ISEcp1 being the most prevalent.

This robust, multi-assay platform ensured high confidence in both the genotypic and phenotypic characterization of resistance determinants (reference_paper).

Protocol Parameters

• plasmid selection assay | 25–170 μg/mL (chloramphenicol) | stringent vs. relaxed plasmids | optimized for variable copy number and stringency | product_spec
• protein synthesis inhibition | ≥25 μg/mL (chloramphenicol) | bacterial translation blockade | inhibits 50S ribosomal peptidyl transferase | product_spec
• plasmid elimination (SDS) | variable temp, SDS concentration | elimination of non-stable plasmids | distinguishes chromosomal vs. plasmid CEGs | reference_paper
• broth microdilution resistance testing | CLSI guidelines | multidrug resistance profiling | ensures comparability across studies | reference_paper

Core Findings and Why They Matter

The analysis yielded several critical observations:

• High Prevalence of CEGs: 85.19% of CREC isolates carried at least one CEG, predominantly blaNDM−1 (source: reference_paper).
• Plasmid Localization Dominates: 46.30% of isolates had blaNDM−1 exclusively on plasmids, while 33.33% presented blaNDM−1 on both chromosomes and plasmids. Only a minority harbored blaIMP or both blaNDM−1 and blaKPC−2 (source: reference_paper).
• Efficient Horizontal Transfer: Conjugation experiments achieved a 95.65% overall CEG transfer success, with blaNDM−1 and blaIMP transferred at 95.45% and 100%, respectively (source: reference_paper).
• Resistance Phenotype: CEG-positive strains exhibited significantly higher resistance to multiple antibiotics, including imipenem and fluoroquinolones, compared to CEG-negative isolates (source: reference_paper).
• Mobile Genetic Elements: Six types of MGEs were detected, with ISEcp1 present in 87.04% of isolates. The co-occurrence of multiple MGEs in a single strain was common, facilitating gene mobility (source: reference_paper).
• Epidemiological Hotspots: Higher detection frequencies were found among male patients (64.81%), elderly individuals (72.22%), respiratory medicine departments (20.37%), and sputum samples (33.33%) (source: reference_paper).
• Genetic Diversity: ERIC-PCR typing grouped isolates into 17 genotypes, with types E and G each representing 20.37% of cases and spanning multiple hospitals, underscoring the broad dissemination of dominant clones (source: reference_paper).

These findings demonstrate that plasmid-mediated blaNDM−1 transmission is a central driver of CREC multidrug resistance and that both horizontal and vertical gene transfer contribute substantially to the regional epidemiology of AMR.

Comparison with Existing Internal Articles

Several internal resources provide context and protocol guidance relevant to this study:

• "Chloramphenicol as a Cornerstone in Translational Antimic..." discusses the strategic use of high-purity chloramphenicol for selection and mechanistic studies on resistance gene transfer, aligning with the reference study’s emphasis on plasmid analysis in CREC.
• "Chloramphenicol: Mechanisms, Applications, and Research B..." elaborates on how chloramphenicol, as a 2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide, is deployed in molecular biology to select for and maintain plasmids encoding resistance genes, providing best practices for experimental reproducibility and gene transfer assays.
• "Transmission Dynamics of Carbapenemase Genes in CREC in China" offers a complementary perspective on the regional spread of CEGs, reinforcing the current study’s findings on plasmid-mediated transmission and genetic diversity.

Together, these articles underscore the relevance of robust selection protocols and molecular validation—such as those enabled by chloramphenicol—in elucidating AMR dynamics and supporting translational research.

Limitations and Transferability

While the study is notable for its multi-center design and molecular depth, several limitations affect the generalizability of its findings:

• The sample size, though substantial, is geographically restricted to Guangdong Province; regional patterns elsewhere may differ.
• PCR-based detection may miss rare or novel CEG variants not targeted by the chosen primers.
• The study does not address the clinical outcomes associated with different CEG genotypes or the impact of interventions.
• Horizontal transfer success in vitro may not fully reflect in vivo conditions due to host and ecological factors.

Nonetheless, the workflow—including plasmid selection assay protocols and resistance profiling—demonstrates high transferability to other laboratory settings investigating bacterial protein synthesis inhibition and AMR gene dynamics.

Research Support Resources

For researchers aiming to replicate or extend this work, careful control of plasmid selection and protein synthesis inhibition is critical. Chloramphenicol (SKU: A2512), a well-characterized 2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide, is widely used as an antimicrobial agent and bacterial protein synthesis inhibitor in plasmid selection assays and resistance gene studies (internal_article). Its mechanism—binding to the bacterial 50S ribosomal subunit—enables stringent selection and facilitates experimental reproducibility when characterizing resistance determinants. APExBIO provides high-purity chloramphenicol suitable for these applications, supporting rigorous workflows in molecular microbiology. Always consult product documentation for precise assay conditions and storage guidance.